SGLT2 Inhibition Attenuates Hippocampal Injury and Cognitive Impairment in Adult-Onset Hypothyroidism. [PDF]
Bitiktaş S +7 more
europepmc +1 more source
Hyponatremia correction is associated with increased brain-derived neurotrophic factor levels: A pilot secondary analysis of a randomized, double-blind, placebo-controlled, crossover trial. [PDF]
Kustos-Tóth E +6 more
europepmc +1 more source
Bioequivalence Evaluation of Immediate-Release Empagliflozin/Metformin Fixed-Dose Combination Tablets Under Fed Conditions in Healthy Mexican Subjects and Exploratory Analysis of Metformin Dose Proportionality. [PDF]
Guido Ávila EG +5 more
europepmc +1 more source
Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways. [PDF]
Al-Mahdawi MA +3 more
europepmc +1 more source
Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial. [PDF]
Kazem-Nadi S +3 more
europepmc +1 more source
Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors: What Have We Learned So Far? [PDF]
Qi L, Wright EM, Cai X.
europepmc +1 more source
Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy. [PDF]
Su N +5 more
europepmc +1 more source
Effect of empagliflozin on copeptin levels in patients with recent acute coronary syndrome and newly detected dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial. [PDF]
Fortin E +8 more
europepmc +1 more source
Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. [PDF]
Hasegawa K +10 more
europepmc +1 more source
Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in <i>db/db</i> Diabetic Mice. [PDF]
Korbut AI +7 more
europepmc +1 more source

